Blood Grants

Oncology Nursing Society Excellence in Blood and Marrow Transplantation Award

Award: Monetary award of $1000 and a plaque.

Purpose: To recognize and support excellence in nurses engaged in blood and marrow transplantation

Nominee's Eligibility Criteria:
The candidate must meet the following criteria:

Be a registered professional nurse and an active ONS member
Have at least two years of oncology nursing experience
Be a recognized expert in the field of blood and marrow transplantation (e.g., through publications, presentations, research, and peer review)
Made a significant contribution to one or more of the following related to blood and marrow transplantation: professional/patient education, clinical practice, and/or nursing research
Serves as a role model for other nurses.

Criteria:
The scoring criteria for judging this nomination is as follows:

ONS involvement: Participation should include involvement at the local or national level.
Includes membership on committees, holding office, or task force participation.
Recognized expert in the field of blood and marrow transplantation, contributing to the development of blood and marrow transplantation.
Includes articles in newsletters, journals, reports, video, multimedia, computer assisted instruction, chapters in books (do not include research here, include research in last criteria point).
Significant contribution to the following areas:
Professional/patient education related to blood and marrow transplantation
Presentations
Examples in letters of role modeling
Specific educational interventions
Program development
Support groups
Adjunct faculty to preceptor for students
Community outreach
Clinical practice related to blood and marrow transplantation:
Theoretical concepts used
Nursing process used
Professional development of self and others
Multidisciplinary collaboration
Quality assurance
Ethical decision-making used
Reviews/applies nursing research
Blood and marrow transplantation research

Application deadline: October 31, 5pm ET.

Oncology Nursing Society
125 Enterprise Drive
Pittsburgh, PA 15275

866-257-4ONS (866-257-4667)
412-859-6100
877-369-5497 (toll free fax)
412-859-6162 (fax)
customer.service@ons.org

Lymphoma Research Foundation 2011-2014 Clinical Investigator Career Development Grant

* 2011-2014 Clinical Investigator Career Development Grant -- $75K per year for 3 years: The Lymphoma Research Foundation (LRF) seeks applications for its 3-year Clinical Investigator Career Development Grant.

The purpose of this grant is to fund training of physician investigators who will participate in developing new therapeutics and diagnostic tools for lymphoma. Physician investigators who are at the level of advanced fellow or junior faculty with no greater than 5 years of experience beyond completion of their fellowship or post-doctoral training are eligible (five year limit may be non-sequential in case of interruptions for pregnancy or illness). The focus of the training is to prepare physician investigators to design and administer clinical research studies in lymphoma and to take on the primary responsibilities for clinical research, protocol writing, Institutional Review Board (IRB) submission and publication. The proposed research plan should develop the necessary knowledge and clinical research skills relevant to the investigator's career goals. The Grant is designed to provide physician investigators with support to spend 35-50% of their time implementing clinical research studies in lymphoma. A Career Development Plan is required as part of the Grant Application.

o Applications are due on September 7, 2010. Applications will be peer-reviewed, and applicants will be notified of results by November 2010.

All applications must be submitted electronically. LRF allows up to 25 percent overhead. Smaller overhead amounts are preferred. To apply for grant opportunities, please go to https://proposalcentral.altum.com

New York Office:
115 Broadway, 13th Floor
New York, NY 10006
Phone: (212) 349-2910, (800) 235-6848
Fax: (212) 349-2886

Los Angeles Office:
8800 Venice Blvd, Suite 207
Los Angeles, CA 90034
Phone: (310) 204-7040, (800) 500-9976
Fax: (310) 204-7043

Lymphoma Research Foundation 2011-2013 Postdoctoral Fellowships

$105K for 2 years

The Lymphoma Research Foundation (LRF) seeks applications for its 2-year Postdoctoral Fellowship award. Projects may be laboratory or clinic based, with the results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/of non-Hodgkin lymphoma. Areas of research may include, but are not limited to, etiology, immunology, genetics, therapies and transplantation.

* Applications are due on September 7, 2010. Applications will be peer-reviewed, and applicants will be notified of results by November 2010.

Application Receipt Date: Sept 7, 2010
Peer Review Process: Sept 2010 – Oct 2010
Applicant Notification Date: Nov 2010
Earliest Project Start Date: Jan 1, 2011

PURPOSE OF FELLOWSHIP
To support research, which may be laboratory or clinic based, with the results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin’s and/or non-Hodgkin’s lymphoma. Areas of research may include, but are not limited to, etiology, immunology, genetics, therapies, and transplantation.

ELIGIBILITY
1. Applicants must have completed two years of their fellowship, or not more than two years as a junior faculty instructor or assistant professor at the start of the award period and hold an M.D., Ph.D., or equivalent degree.
2. Applicants must be affiliated with a sponsoring institution in the U.S. or Canada for the duration of the LRF Grant. Citizenship is not required.
3. Applicant must secure a Sponsor who will supervise the proposed research project. The Sponsor’s role is to assure (on behalf of the Institution) that the specific aims of the project are met and to present the Institution’s role in the development of the Applicant’s career. The Sponsor may support only one applicant.
4. Applications are encouraged from qualified individuals without regard to age, race, religion, sex, creed, national origin, or any other characteristics protected by law.
5. All LRF applications are self-initiated. LRF does not invite applications from selected individuals or laboratories.
6. The Fellow must spend a minimum of 80 percent of his/her time in research without major patient care, teaching, or administrative responsibilities except as such responsibilities relate directly to a pre-clinical or clinical lymphoma research project.
7. The LRF Fellow may not hold another competitively applied for fellowship title during the period of the LRF Grant. However, LRF Grants may be supplemented by funds from other sources. LRF must be informed as to the sources and the amounts of all other funding received by the LRF Fellow during the term of the LRF Grant. Failure to comply may result in termination of the LRF Grant.
8. There is no restriction on the number of times an individual may apply for an LRF Grant.
9. A previous LRF Fellow shall not be granted support other than in exceptional circumstances, which is decided on a case-by-case basis.

In our efforts to improve our grant process, the Lymphoma Research Foundation will be using an electronic grants submission process. All interested grant applicants must submit their applications online through proposalCENTRAL (https://proposalcentral.altum.com).

To avoid being rushed at deadline time, applicants are encouraged to register and complete a professional profile at proposalCENTRAL now. Applicants should make sure their grants and contracts office has registered their institution and signing officials with proposalCENTRAL.

New York Office:
115 Broadway, 13th Floor
New York, NY 10006
Phone: (212) 349-2910, (800) 235-6848
Fax: (212) 349-2886

Los Angeles Office:
8800 Venice Blvd, Suite 207
Los Angeles, CA 90034
Phone: (310) 204-7040, (800) 500-9976
Fax: (310) 204-7043

Leukemia & Lymphoma Society's Career Development Program

The Leukemia & Lymphoma Society's (LLS's) Career Development Program (CDP) provides awards intended to meet the specific needs of investigators at different states in their research careers. The awards - Scholar, Scholar in Clinical Research, Special Fellow, Special Fellow in Clinical Research and Fellow - provide stipends to investigators, allowing them to devote themselves to research bearing on leukemia, lymphoma and myeloma.

The CDP supports fundamental research in genetics, molecular and cell biology, molecular pharmacology, molecular virology and immunology. The program also encompasses translational research directly relevant to the improved treatment or diagnosis of leukemia, lymphoma, myeloma and, where applicable, to prevention.

Effective Award Year 2011

Scholar
Scholars are highly qualified investigators who have shown a capacity for independent, sustained original investigation in the field of leukemia, lymphoma, and myeloma. These Scholars are expected to hold independent faculty-level or equivalent positions and have obtained substantial support for their research from a national agency. Scholar awards are for up to $110,000 per year for five years. Annual renewals are based on a non-competitive progress report review.

Scholar in Clinical Research
Scholars in Clinical Research are highly qualified investigators who are expected to hold independent faculty-level appointments and who are conducting original, independent applied research, often involving early-stage clinical trials which will advance the prevention, diagnosis or treatment of hematologic malignancies. These Scholars are expected to have concomitant support for their research from another source or agency. Scholar in Clinical Research awards are for up to $110,000 per year for five years. Annual renewals are based on a non-competitive progress report review.

Special Fellow
Special Fellows are qualified investigators who have completed a minimum of two years of postdoctoral research training and are continuing their research under the direction of a research Sponsor. The Special Fellowship should permit the scientist to begin to transition to an independent research program. Special Fellow awards are for up to $65,000 per year for three years. Annual renewals are based on a non-competitive progress report review.

Special Fellow in Clinical Research (SFCR)
Special Fellows are researchers who hold a Ph.D., M.D. or equivalent degree and have completed a minimum of two years of clinical hematology, oncology, hematology/oncology or hematopathology training or postdoctoral research training in a clinical discipline (e.g., cytogenetics, molecular pathology). These grantees should provide evidence that their career focus will be on the prevention, diagnosis, or treatment of leukemia, lymphoma, or myeloma. SFCR awards are for up to $65,000 per year for three years. Annual renewals are based on a non-competitive progress report review.

Fellow
Fellows are promising investigators with less than two years of postdoctoral research training. These grantees are encouraged to embark on an academic career involving clinical or fundamental research in, or related to, leukemia, lymphoma or myeloma under the direction of a research sponsor. Fellow awards are for up to $55,000 per year for three years. Annual renewals are based on a non-competitive progress report review.

Deadlines
A letter of intent is mandatory for those applying for a Career Development Program grant and must be completed online via proposalCentral by 3 p.m. ET, Sept. 15.

Full applications must be received electronically via proposalCentral by 3 p.m. ET, Oct. 1.

Our program is now open. Please apply via proposalCENTRAL.

For more program information, contact:

The Leukemia & Lymphoma Society
1311 Mamaroneck Ave.
White Plains, NY 10605
Telephone: (914) 821-8301, (914) 821-8290, researchprograms@lls.org .

2010–2011 Phlebotomy Student Scholarships

You could receive one of the $500 scholarships awarded by the American Society for Clinical Pathology. We are searching for the best future medical laboratory professionals. If you are currently enrolled in or a recent graduate of (within the last 9 months from the date this application is filed) an approved phlebotomy training program, you may be eligible to receive one of the scholarships. Students who are completing phlebotomy training as a component of a MT/CLS/MLS or MLT/CLT Program are not eligible for a phlebotomy scholarship.

Approved programs include:
NAACLS-approved phlebotomy program Phlebotomy program approved by the applicant’s State Department of Health Sciences

Phlebotomy program that meets the ASCP Board of Certification Route 2 eligibility criteria

Selection Criteria

Professional goals
Leadership abilities
Community activities

Postmark deadline: November 15, 2010

ASCP Student Scholarship Program 33 W. Monroe St., Suite 1600 Chicago, IL 60603-5617
 

National Hemophilia Foundation Judith Graham Poole Postdoctoral Research Fellowship

Letter of Intent Deadline: November 23, 2010
Application Deadline: February 23, 2011
Award Start Date: July 1, 2011

The program is named for Dr. Judith Graham Pool. In 1965, Dr. Pool discovered a simple method of extracting the clotting factor from human plasma. This opened the door to a series of rapid developments that revolutionized the treatment of hemophilia including replacement therapy. Replacement therapy (i.e., the infusion of the missing clotting factor to prevent or stop bleeding) has made it possible for people with hemophilia to live relatively normal and productive lives and to avoid, in large measure, the potentially crippling effects of the disorder.

Only noncommercial institutions and investigators associated with a noncommercial institution are eligible for NHF funding.

All grant and fellowship applications are subjected to a rigorous peer review process. Applications are critiqued on scientific merit and relevance to NHF research priorities. Applications are reviewed and scored in terms of significance, approach, innovation, investigator, and environment. A panel selected by the Research Working Group, a volunteer group of scientific and lay leaders, reviews applications received.

Eligibility
Applicants must have completed doctoral training and must enter the JGP fellowship program from a doctoral, postdoctoral, internship or residency training program. Established investigators or faculty members are not eligible. Applicants must be affiliated with domestic organizations such as universities, colleges, hospitals and laboratories. US citizenship is not required.

Permissible research topics include clinical or basic research on the biochemical, genetic, hematologic, orthopedic, psychiatric or dental aspects of the hemophilias or von Willebrand disease. Other topics include rehabilitation, therapeutic modalities, psychosocial issues, women's health issues, liver disease, or AIDS/HIV as they pertain to the hemophilias or von Willebrand disease.

It is expected that the fellow will spend at least 90% of the time on the research project for which funding is requested. The remaining 10% may be devoted to teaching or clinical work that is relevant to the research.

Funding
Support is available for up to $42,000/per year for a maximum of two years (pending continuing grant approval).

Letter of Intent
All interested candidates must submit a letter of intent by 5pm EST, November 23, 2010. This should be a brief letter identifying the researcher, their mentor, institution and a description of the proposed research project. Letters of intent should include an NIH-style CV or biosketch for both candidate and mentor. Letters of intent will be evaluated by members of NHF's Research Review Committee who will collectively decide upon the candidates invited to submit a full JGP application.

Inquiries
For further information, contact:

Angelina Wang
Director of Research and Medical Information
116 West 32nd Street, 11th floor
New York, NY 10001
Phone: (212) 328-3727 or (800) 42-HANDI ext. 3727
Fax: (212) 328-3799
E-mail: awang@hemophilia.org

American Society of Hematology Alternative Training Pathway Grant

The Alternative Training Pathway Grant is intended to foster the development and/or implementation of creative new curricula for trainees in clinical and clinical/translational hematology and related fields. A growing number of trainees are expressing an interest in pursuing hybrid careers (e.g., medicine/pediatrics) and/or a desire to become trained in both clinical care and laboratory medicine (e.g., transfusion medicine or directing hemostasis laboratories). There is a perceived need for specialists with integrated expertise in hematology and other rapidly evolving areas of applied medicine such as vascular biology, stem cell technologies, cellular therapeutics, and targeted pharmacotherapeutics, laboratory oversight, and transfusion medicine. The Alternative Training Pathway Grant is designed to allow training program directors the opportunity to develop curricula that meets these new demands. Examples of previously funded initiatives include integrated pathways in adult and pediatric benign hematology; pediatric hemostasis-thrombosis and pharmacology; and hematology and palliative care.

Support

Grants of up to $50,000 will be awarded to support the development and implementation of novel hematology-related training programs as an alternative to traditional training programs. The award may be expended over a one- to two-year period of time. No institutional overhead (i.e., indirect) costs will be supported by this grant.
Eligibility

Applicants must be Training Program Directors and other educators, and Active Members of the American Society of Hematology (ASH) at institutions with an accredited training program(s) in adult or pediatric hematology or hematology/medical oncology, or in other hematology-related disciplines (e.g., pathology specialties) in the United States, Canada, or Mexico. Awards are limited to only one application per institution. Awardees must commit to providing progress reports and final reports as defined in the terms of the grant.

Proposed Curriculum

The proposed curriculum should be able to integrate within an accredited hematology, hematology/oncology, and/or hematology-related specialty training program. Inter-disciplinary initiatives are encouraged, and multi-institutional programs will be considered.

Applicants should:

* Describe the proposed new or alternative training pathway(s).
* Discuss how career development and the scope of career opportunities will be enhanced through the proposed training pathway(s).
* If an inter-disciplinary initiative is proposed, describe how cross-training and certification in fields related to hematology may be pursued or how defined specialty barriers might be breached (e.g., medicine and pediatrics).
* Describe how the curriculum could be disseminated to other training programs if applicable.
* Describe plans to achieve sustainability of the pathway over time.

Examples of innovative pathways include: 1) Hematology and Laboratory Oversight Pathways (e.g. Special Coagulation Laboratory); 2) Hematology and Transfusion Medicine with an emphasis on apharesis.

Letter of Intent

Letters of Intent for the 2011 application cycle will be due via e-mail no later than 5:00 p.m. EST, on Tuesday, February 2, 2011. Those who have fulfilled the Letter of Intent requirements will be invited to apply.

Questions regarding this application and the ASH Alternative Training Pathway Grant should be directed to Joe Basso, Training Manager, at jbasso@hematology.org or 202-552-4910.

Audi Gerstein Platelet Disorder Scholarship for Undergraduate/Graduate Students with Platelet Disorders

Awards are restricted to senior high school students, current college students, or adults interested in
continuing education who have ITP or a similar inherited or non-inherited diagnosed platelet disorder.

The Scholarship award is intended to assist full-time undergraduate or graduate students entering or
attending an accredited technical school, two or four year college, university or graduate school in the
United States.

The Applicant must be a U.S. Citizen. There is no GPA requirement, however, the
applicant must have acceptance to the college of their choice. Former Scholarship recipients are not
permitted to reapply (those who have won book awards are eligible). Family members of ITP patients
or PDSA board members or Scholarship committee members are not eligible to apply.

The Process
A 700 – 1,000 word essay is required which details how your platelet disorder has resulted in your
growth as a person; what you learned about your own strengths and weaknesses. If you feel its
changed you, whether emotionally or physically, describe how it changed your approach to life and
relationships. Describe how having an illness might have affected your life's s accomplishments and
helped you set goals. If you feel that having a chronic illness has helped you choose a career path,
describe how, and explain why you feel this way and what you have done to meet these educational
goals. Explain what your plans are for the future in meeting your educational responsibilities, in light of
your struggles with a platelet disorder.

An Application will be due and submitted to the PDSA no earlier than March 15 and no later than
April 15. Awards will be announced by May 15. Incomplete or late Applications will not be considered.

Scholarship award winners will be announced on our website. The essays and applications will be
reviewed and judged by an impartial panel selected by the PDSA Board of Directors.

Scholarship Funds
Scholarship Funds will be awarded in a one-time payment of $1,000 during the academic year.
Payments will be made directly to the institution prior to the start of the fall semester.

Platelet Disorder Support Association
133 Rollins Avenue, #5
Rockville, MD 20852

Phone: 1- 87-PLATELET 877-528-3538 (toll free) or 301-770-6636

Fax: 301-770-6638 - e-mail: pdsa@pdsa.org

National Hemophilia Foundation Physical Therapy Excellence Fellowship

Letter of intent submission deadline February 1, 2011

All grant and fellowship applications are subjected to a rigorous peer review process. Applications are critiqued on scientific merit and relevance to NHF research priorities. Applications are reviewed and scored in terms of significance, approach, innovation, investigator, and environment. A volunteer group of scientific and lay leaders reviews applications received. The NHF Medical and Scientific Advisory Council (MASAC) and the NHF Board of Directors grant final funding approval.

Eligibility
The objectives of the Physical Therapy Fellowship are to improve the delivery of physical therapy care and expand the knowledge base specific to hemophilia.

It is expected that the fellowship will provide support for a physical therapist currently employed or interested in hemophilia care to conduct physical therapy research or clinical projects related to the care of the patient with hemophilia.

Current topics of interest may include but are not limited to the following: development of clinical pathways, physical therapy protocols, physical therapy utilization, measurable outcome studies, rehabilitation programs, use of modalities and other intervention commonly used by physical therapists in the treatment of the patient with hemophilia.

Funding
NHF awards one new research fellowship per year of $10,000. Awards are made for one calendar year.

Deadlines

A letter of intent should be submitted to NHF. This should be a brief letter identifying the applying researcher and organization and the intended area of research.

Multidisciplinary applications are welcomed. If a multidisciplinary project is sought, you are encouraged to indicate in the letter of intent and in the application how the project would proceed if only one Fellowship is awarded.

Inquiries
For inquiries regarding applications, policy and procedures and programmatic information, contact:

Morgan Johnson, CAE, Manager of Healthcare Provider Programs
National Hemophilia Foundation
116 West 32nd Street, 11th Floor
New York, NY 10001
(800) 424-2634 ext. 3745 or (212) 328-3745
Fax: (212) 328-3799
E-mail: mjohnson@hemophilia.org

Direct inquiries regarding fiscal matters to:

Department of Finance and Administration
National Hemophilia Foundation
116 West 32nd Street, 11th Floor
New York, NY 10001
(800) 424-2634 ext. 3726 or (212) 328-3726
Fax 212-328-3766

National Hemophilia Foundation Social Work Excellence Fellowships

Letter of intent submission deadline February 1, 2011

All grant and fellowship applications are subjected to a rigorous peer review process. Applications are critiqued on scientific merit and relevance to NHF research priorities. Applications are reviewed and scored in terms of significance, approach, innovation, investigator, and environment. A panel selected by the Research Working Group, a volunteer group of scientific and lay leaders, reviews applications received. The NHF Medical and Scientific Advisory Council (MASAC) and the NHF Board of Directors grant final funding approval.

Eligibility
To be eligible for the fellowship the applicant must: be an MSW from an accredited school of social work or be a student in a DSW program or have a master's degree in a social work related field, be licensed by the state to practice as a master's level clinical social worker and work in a bleeding disorders program. Professional experience in a hemophilia treatment center is desirable but not required. The proposed project, however, must have relevance to current practice in bleeding disorders care and may incorporate casework, group work, organizational and public health, education and research perspectives.

It is expected that the project will: (1) promote the integration of psychosocial care with biomedical components of comprehensive care; (2) promote the delivery of quality services to patients and families; (3) contribute to the literature on the psychosocial aspects of bleeding disorders; (4) demonstrate social work outcomes of the research or clinical project.

Areas of research interest might include some of the following topics: impact of social work practice on coping with chronic illness and/or disability; impact of case management on patient care; improved clinical practice; research skills and goals for psychosocial providers; mental health issues of those affected with bleeding disorders or bleeding disorders/HIV; development and use of media projects and/or learning tools for professional or patient evaluation. A focus on cultural diversity is welcomed.

Funding
NHF awards one new research fellowship per year of $10,000.

Deadlines

A letter of intent should be submitted to NHF. This should be a brief letter identifying the applying researcher and organization and the intended area of research.

Multidisciplinary applications are welcomed. If a multidisciplinary project is sought, you are encouraged to indicate in the letter of intent and in the application how the project would proceed if only one Fellowship is awarded.

Inquiries
For inquiries regarding applications, policy and procedures and programmatic information, contact:

Morgan Johnson, CAE, Manager of Healthcare Provider Programs
National Hemophilia Foundation
116 West 32nd Street, 11th Floor
New York, NY 10001
(800) 424-2634 ext. 3745 or (212) 328-3745
Fax: (212) 328-3799
E-mail: mjohnson@hemophilia.org

Direct inquiries regarding fiscal matters to:

Department of Finance and Administration
National Hemophilia Foundation
116 West 32nd Street, 11th Floor
New York, NY 10001
(800) 424-2634 ext. 3726 or (212) 328-3726
Fax 212-328-3766